SCHEMBL10150481

SCHEMBL10150481

CCOC(=O)OC12CC3CC(C1)C(=O)C(C3)C2

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.53
TSHR P16473 1/20 0.53
EPHX2 P34913 2/20 0.41
LMNA P02545 1/20 0.37
NAAA Q02083 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
ALDH1A1 P00352 3/20 0.35
CYP19A1 P11511 3/20 0.35
MEN1 O00255 1/20 0.34
HTT P42858 1/20 0.34
KMT2A Q03164 1/20 0.34
CYP17A1 P05093 2/20 0.33
SOAT1 P35610 1/20 0.33
HPGD P15428 1/20 0.33
MAPK1 P28482 1/20 0.33
RECQL P46063 1/20 0.33
CNR2 P34972 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1439742 0.85 LMNA (0.47) NPSR1TSHREPHX2LMNACYP3A4
SCHEMBL22590265 0.85 TSHR (0.53) NPSR1TSHREPHX2NAAACYP19A1
SCHEMBL2603074 0.81 NPSR1 (0.63) NPSR1TSHREPHX2NAAAALDH1A1
SCHEMBL12430198 0.79 NPSR1 (0.51) NPSR1TSHREPHX2LMNANAAA
SCHEMBL231596 0.79 NPSR1 (0.56) NPSR1TSHREPHX2NAAAALDH1A1
SCHEMBL1397825 0.77 NPSR1 (0.47) NPSR1TSHREPHX2LMNACYP2C9
SCHEMBL12412376 0.77 NPSR1 (0.51) NPSR1TSHREPHX2NAAAALDH1A1
SCHEMBL26061859 0.77 TSHR (0.58) NPSR1TSHREPHX2NAAACYP19A1
SCHEMBL11991220 0.76 TSHR (0.50) NPSR1TSHREPHX2NAAACYP19A1
SCHEMBL12705217 0.76 TSHR (0.53) NPSR1TSHREPHX2NAAACYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173350-B2 Oxime compound and resist composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-05-08 US disclosed
US-8173350-B2 Oxime compound and resist composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-05-08 US disclosed
US-20100021847-A1 Oxime Compound and Resist Composition Containing the Same SUMITOMO CHEMICAL COMPANY, LTD. (JP) 2010-01-28 US disclosed
US-20100021847-A1 Oxime Compound and Resist Composition Containing the Same SUMITOMO CHEMICAL COMPANY, LTD. (JP) 2010-01-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100021847-A1 Oxime Compound and Resist Composition Containing the Same CYC1, UQCRB, CBR1 NPSR1 2324/4885TSHR 841/4885EPHX2 1489/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.